natgillin/translations-raw huggingface dataset:
Commission Implementing Regulation (EU) 2015/408
Izvedbena uredba Komisije (EU) 2015/408
on implementing Article 80(7) of Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market and establishing a list of candidates for substitution
o izvajanju člena 80(7) Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet in pripravi seznama kandidatk za zamenjavo
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC [1], and in particular Article 78(2) thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS [1] in zlasti člena 78(2) Uredbe,
Active substances are to be identified as candidates for substitution if they meet one or more criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009.
Aktivne snovi se opredelijo kot kandidatke za zamenjavo, če izpolnjujejo eno ali več meril iz točke 4 Priloge II k Uredbi (ES) št. 1107/2009.
Pursuant to Article 80(7) of Regulation (EC) No 1107/2009, the Commission has to establish a list of substances included in Annex I to Council Directive 91/414/EEC [2] which satisfy the criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009, hereinafter: ‘list of candidates for substitution’.
V skladu s členom 80(7) Uredbe (ES) št. 1107/2009 mora Komisija pripraviti seznam snovi, vključenih v Prilogo I k Direktivi Sveta 91/414/EGS [2], ki izpolnjujejo merila, določena v točki 4 Priloge II k Uredbi (ES) št. 1107/2009 (v nadaljnjem besedilu: seznam kandidatk za zamenjavo).
To ensure the consistency of the policy of the Union as regards active substances that have properties identifying them as candidates for substitution and to apply equal treatment to such substances, the Commission should also include in that list active substances approved under Regulation (EC) No 1107/2009 pursuant to the transitional provisions of Article 80(1).
Za zagotovitev doslednosti politike Unije glede aktivnih snovi, ki imajo lastnosti, na podlagi katerih se lahko opredelijo kot kandidatke za zamenjavo, in enake obravnave tovrstnih snovi bi morala Komisija na navedeni seznam vključiti tudi aktivne snovi, ki so bile odobrene na podlagi Uredbe (ES) št. 1107/2009 v skladu s prehodnimi določbami iz člena 80(1).
From the information contained in either the review report, or the conclusions of the European Food Safety Authority [3] or the Draft Assessment Report and related addenda and peer review reports, or from the classification in accordance with Regulation (EC) No 1272/2008 of the European Parliament and of the Council [4], it was possible to identify the substances which satisfy the criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009.
Na podlagi informacij iz poročila o pregledu, sklepov Evropske agencije za varnost hrane [3], osnutka poročila o oceni ter s tem povezanih dodatkov in poročil o medsebojnih pregledih ali na podlagi razvrščanja v skladu z Uredbo (ES) št. 1272/2008 Evropskega parlamenta in Sveta [4] je bilo mogoče opredeliti snovi, ki izpolnjujejo merila iz točke 4 Priloge II k Uredbi (ES) št. 1107/2009.
These documents provide information, where relevant, concerning the applicable Acceptable Daily Intake (ADI), Acute Reference Dose (ARfD) or Acceptable Operator Exposure Level (AOEL), the information concerning persistent, bio-accumulative and toxic (PBT) properties of the substances, information concerning critical effects referred to in the third indent of point 4 of Annex II to Regulation (EC) No 1107/2009, the proportion of non-active isomers, the classification in accordance with Regulation (EC) No 1272/2008, as carcinogen category 1A or 1B and toxic for reproduction category 1A or 1B, the endocrine disrupting properties.
Ti dokumenti, kjer je to ustrezno, vsebujejo informacije v zvezi z veljavnim sprejemljivim dnevnim vnosom (ADI), akutnim referenčnim odmerkom (ARfD) ali dopustno ravnjo izpostavljenosti izvajalca (AOEL), informacije v zvezi z obstojnimi, bioakumulacijskimi in strupenimi (PBT) lastnostmi snovi, informacije v zvezi s kritičnimi učinki iz tretje alinee točke 4 Priloge II k Uredbi (ES) št. 1107/2009, deležem neaktivnih izomerov, razvrščanjem v skladu z Uredbo (ES) št. 1272/2008 med rakotvorne snovi iz kategorije 1A ali 1B in med snovi, strupene za razmnoževanje, iz kategorije 1A ali 1B, lastnostmi motilcev hormonskega ravnovesja.
Based on that information, the substances set out in the Annex to this Regulation were identified as satisfying one or more criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009.
Na podlagi navedenih informacij je bilo za snovi iz Priloge k tej uredbi ugotovljeno, da izpolnjujejo eno ali več meril iz točke 4 Priloge II k Uredbi (ES) št. 1107/2009.
The information has been consolidated and can be found in a support tool for the establishment of the list of candidates for substitution, which is available on the Commission website [5].
Informacije so bile konsolidirane in jih je mogoče najti v podpornem orodju za pripravo seznama kandidatk za zamenjavo, ki je na voljo na spletišču Komisije [5].
The Acceptable Daily Intake (ADI) of the active substances 1-methylcyclopropene, amitrole, diclofop, dimethoate, ethoprophos, fenamiphos, fipronil, fluometuron, haloxyfop-P, metam, oxamyl, sulcotrione and triazoxide is significantly lower than that of the majority of the approved active substances within their respective groups of substances/use categories.
Vrednost sprejemljivega dnevnega vnosa (ADI) aktivnih snovi 1-metilciklopropen, amitrol, diklofop, dimetoat, etoprofos, fenamifos, fipronil, fluometuron, haloksifop-P, metam, oksamil, sulkotrion in triazoksid je bistveno nižja od vrednosti večine odobrenih aktivnih snovi znotraj posameznih skupin snovi/kategorij rabe.
The Acute Reference Dose (ARfD) of the active substances dimoxystrobin, fenamiphos, methomyl and oxamyl is significantly lower than that of the majority of the approved active substances within their respective groups of substances/use categories.
Vrednost akutnega referenčnega odmerka (ARfD) aktivnih snovi dimoksistrobin, fenamifos, metomil in oksamil je bistveno nižja od vrednosti večine odobrenih aktivnih snovi znotraj posameznih skupin snovi/kategorij rabe.
The Acceptable Operator Exposure Level (AOEL) of the active substances amitrole, bromadiolone, difenacoum, dimethoate, diquat, ethoprophos, fenamiphos, fluquinconazole, metam, sulcotrione, triazoxide and warfarin is significantly lower than that of the majority of the approved active substances within their respective groups of substances/use categories.
Vrednost dopustne ravni izpostavljenosti izvajalca (AOEL) aktivnih snovi amitrol, bromadiolon, difenakum, dimetoat, dikvat, etoprofos, fenamifos, flukvinkonazol, metam, sulkotrion, triazoksid in varfarin je bistveno nižja od vrednosti večine odobrenih aktivnih snovi znotraj posameznih skupin snovi/kategorij rabe.
It is therefore appropriate to include those active substances in the list of candidates for substitution.
Zato je navedene aktivne snovi primerno vključiti na seznam kandidatk za zamenjavo.
The active substances lufenuron, oxyfluorfen and quinoxyfen meet the criteria to be considered a persistent and bioaccumulative substance.
Aktivne snovi lufenuron, oksifluorfen in kvinoksifen izpolnjujejo merila, na podlagi katerih se lahko štejejo za obstojno in bioakumulacijsko snov.
The active substances amitrole, bifenthrin, bromuconazole, chlorotoluron (unstated stereochemistry), copper compounds (variants copper hydroxide, copper oxychloride, copper oxide, Bordeaux mixture and tribasic copper sulphate), cyproconazole, cyprodinil, difenoconazole, diflufenican, dimoxystrobin, diquat, epoxiconazole, fenbutatin oxide, fludioxonil, flufenacet, fluopicolide, fluquinconazole, haloxyfop-P, imazamox, imazosulfuron, isoproturon, isopyrazam, lenacil, lufenuron, metconazole, metribuzin, metsulfuron-methyl, myclobutanil, nicosulfuron, oxadiazon, oxyfluorfen, paclobutrazol, pirimicarb, prochloraz, propiconazole, propoxycarbazone, prosulfuron, quinoxyfen, tebuconazole, tebufenpyrad, tepraloxydim, tri-allate, triasulfuron and ziram meet the criteria to be considered a persistent and toxic substance.
Aktivne snovi amitrol, bifentrin, bromukonazol, klorotoluron (stereokemija ni navedena), bakrove spojine (različice bakrov hidroksid, bakrov oksiklorid, bakrov oksid, bordojska mešanica in trivalentni bakrov sulfat), ciprokonazol, ciprodinil, difenokonazol, diflufenikan, dimoksistrobin, dikvat, epoksikonazol, fenbutatin oksid, fludioksonil, flufenacet, fluopikolid, flukvinkonazol, haloksifop-P, imazamoks, imazosulfuron, izoproturon, izopirazam, lenacil, lufenuron, metkonazol, metribuzin, metsulfuron metil, miklobutanil, nikosulfuron, oksadiazon, oksifluorfen, paklobutrazol, pirimikarb, prokloraz, propikonazol, propoksikarbazon, prosulfuron, kvinoksifen, tebukonazol, tebufenpirad, tepraloksidim, trialat, triasulfuron in ziram izpolnjujejo merila, na podlagi katerih se lahko štejejo za obstojno in strupeno snov.
The active substances aclonifen, difenacoum, esfenvalerate, etofenprox, etoxazole, famoxadone, lambda-cyhalothrin, lufenuron, oxyfluorfen, pendimethalin and quinoxyfen meet the criteria to be considered a bioaccumulative and toxic substance.
Aktivne snovi aklonifen, difenakum, esfenvalerat, etofenproks, etoksazol, famoksadon, lambda-cihalotrin, lufenuron, oksifluorfen, pendimetalin in kvinoksifen izpolnjujejo merila, na podlagi katerih se lahko štejejo za bioakumulacijsko in strupeno snov.
The active substances mecoprop and metalaxyl contain a significant proportion of non-active isomers.
Aktivni snovi mekoprop in metalaksil vsebujeta velik delež neaktivnih izomerov.
Since measures concerning specific scientific criteria for the determination of endocrine disrupting properties, as referred to in the first paragraph of point 3.6.5 of Annex II to Regulation (EC) No 1107/2009, have not yet been adopted, it was to be established in accordance with the third paragraph thereof whether a substance is to be considered as having such properties.
V skladu z navedeno določbo se za aktivne snovi klorotoluron (stereokemija ni navedena), dimoksistrobin, epoksikonazol, molinat, profoksidim, tepraloksidim in tiakloprid šteje, da imajo lastnosti motilcev hormonskega ravnovesja, ki lahko škodljivo vplivajo na ljudi.
In accordance with that provision the active substances chlorotoluron (unstated stereochemistry), dimoxystrobin, epoxiconazole, molinate, profoxydim, tepraloxydim and thiacloprid are to be considered as having endocrine disrupting properties that may cause adverse effects in humans.
Državam članicam in zainteresiranim stranem bi bilo treba zagotoviti razumen rok, da se prilagodijo določbam te uredbe.
Member States and interested parties should be provided with a reasonable period to adapt to the provisions of this Regulation.
Ukrepi iz te uredbe so v skladu z mnenjem Stalnega odbora za rastline, živali, hrano in krmo –
Article 1
Kandidatke za zamenjavo
Candidates for substitution
Aktivne snovi iz Priloge I k Direktivi 91/414/EGS, ki izpolnjujejo merila iz točke 4 Priloge II k Uredbi (ES) št. 1107/2009, so navedene na seznamu iz Priloge k tej uredbi.
Active substances included in Annex I to Directive 91/414/EEC which fulfil the criteria set out in point 4 of Annex II to Regulation (EC) No 1107/2009 shall be as set out in the list in the Annex to this Regulation.
Prvi odstavek se uporablja tudi za aktivne snovi, ki so bile odobrene na podlagi Uredbe (ES) št. 1107/2009 v skladu s prehodnimi ukrepi iz člena 80(1).
The first paragraph shall also apply to active substances approved under Regulation (EC) No 1107/2009 pursuant to the transitional measures of Article 80(1).
Člen 2
Article 2
Prehodni ukrepi
Transitional measures
Člen 1 in Priloga se ne uporabljata za vloge za registracijo fitofarmacevtskih sredstev, ki so bile vložene pred 1. avgustom 2015.
Article 1 and the Annex shall not apply to applications for the authorisation of plant protection products submitted before 1 August 2015.
Člen 3
Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market (OJ L 230, 19.8.1991, p. 1).
Uredba (ES) št. 1272/2008 Evropskega parlamenta in Sveta z dne 16. decembra 2008 o razvrščanju, označevanju in pakiranju snovi ter zmesi, o spremembi in razveljavitvi direktiv 67/548/EGS in 1999/45/ES ter spremembi Uredbe (ES) št. 1907/2006 (UL L 353, 31.12.2008, str. 1).
Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).
PRILOGA
ANNEX
etilciklopropen
carbendazim
klorotoluron (stereokemija ni navedena)
chlorotoluron (unstated stereochemistry)
bakrove spojine (različice bakrov hidroksid, bakrov oksiklorid, bakrov oksid, bordojska mešanica in trivalentni bakrov sulfat)
difenoconazole
diflufenikan
diflufenican
dimetoat
dimethoate
dimoksistrobin
dimoxystrobin
dikvat
diquat
epoksikonazol
epoxiconazole
esfenvalerat
esfenvalerate
etoprofos
etofenprox
etoksazol
etoxazole
famoksadon
famoxadone
fenamifos
fenamiphos
fenbutatin oksid
fenbutatin oxide
fludioksonil
fludioxonil
fluopikolid
flumioxazine
glufosinat
fluopicolide
imazamoks
fluquinconazole
izoproturon
glufosinate
izopirazam
haloxyfop-P
lambda-cihalotrin
imazamox
mekoprop
isopyrazam
metomil
lambda-cyhalothrin
metsulfuron metil
mecoprop
oksadiargil
metalaxyl
oksadiazon
metconazole
oksifluorfen
methomyl
paklobutrazol
metsulfuron-methyl
pirimikarb
molinate
prokloraz
myclobutanil
profoksidim
nicosulfuron
propikonazol
oxadiargyl
propoksikarbazon
oxadiazon
kvinoksifen
oxamyl
kvizalofop-P (različica kvizalofop-P-tefuril)
oxyfluorfen
sulkotrion
paclobutrazol
tebukonazol
pendimethalin
tebufenpirad
pirimicarb
tepraloksidim
prochloraz
tiakloprid
profoxydim
trialat
propiconazole
triazoksid
propoxycarbazone
varfarin
quinoxyfen
http://www.efsa.europa.eu/en/publications/efsajournal.htm.
quizalofop-P (variant quizalofop-P-tefuryl)
http://ec.europa.eu/food/plant/pesticides/index_en.htm.
Commission Implementing Regulation (EU) 2015/409
Izvedbena uredba Komisije (EU) 2015/409
amending Council Implementing Regulation (EU) No 917/2011 imposing a definitive anti-dumping duty and collecting definitely the provisional duty imposed on imports of ceramic tiles originating in the People's Republic of China
o spremembi Izvedbene uredbe Sveta (EU) št. 917/2011 o uvedbi dokončne protidampinške dajatve in dokončnem pobiranju začasne dajatve, uvedene na uvoz keramičnih ploščic s poreklom iz Ljudske republike Kitajske
Having regard to Council Regulation (EC) No 1225/2009 of 30 November 2009 on protection against dumped imports from countries not members of the European Community [1] (‘the basic Regulation’), and in particular Article 11(3) thereof,
ob upoštevanju Uredbe Sveta (ES) št. 1225/2009 z dne 30. novembra 2009 o zaščiti proti dampinškemu uvozu iz držav, ki niso članice Evropske skupnosti [1] („osnovna uredba“), in zlasti člena 11(3) Uredbe,
On 15 September 2011 the Council imposed anti-dumping duties on imports of ceramic tiles originating in the People's Republic of China by Implementing Regulation (EU) No 917/2011 [2] (‘the original Regulation’).
Svet je 15. septembra 2011 z Izvedbeno Uredbo (EU) št. 917/2011 [2] („prvotna uredba“) uvedel protidampinške dajatve na uvoz keramičnih ploščic s poreklom iz Ljudske republike Kitajske.
A single duty rate of 26,3 % was imposed on imports of the product concerned manufactured by the following group of exporting producers:
Enotna stopnja dajatve v višini 26,3 % je bila uvedena za uvoz zadevnega izdelka, ki ga proizvajajo naslednji proizvajalci izvozniki:
Dongguan City Wonderful Ceramics Industrial Park Co., Ltd and Guangdong Jiamei Ceramics Co.
Dongguan City Wonderful Ceramics Industrial Park Co., Ltd in Guangdong Jiamei Ceramics Co.
Ltd (together referred to as the Wonderful group), and
Ltd (skupaj „skupina Wonderful“) ter
Ltd and Foshan Gani Ceramics Co.
Ltd in Foshan Gani Ceramics Co.
Ltd (together referred to as the Gani group).
Ltd (skupaj „skupina Gani“).
As set out in recitals 96 to 98 of the original Regulation, the European Commission (‘the Commission’) was notified after disclosure of provisional findings that the relationship between the companies had been severed and on that basis individual duties for the Gani group and for the Wonderful group should have been applied.
Kot je pojasnjeno v uvodnih izjavah 96 do 98 prvotne uredbe, je bila Evropska komisija („Komisija“) po razkritju začasnih ugotovitev obveščena, da je bila povezava med družbami prekinjena, in na podlagi tega bi bilo treba določiti individualni dajatvi za skupino Gani in skupino Wonderful.
On 2 October 2012 the Commission received a request for a partial interim review from the Gani group.
Komisija je 2. oktobra 2012 prejela zahtevek za delni vmesni pregled od skupine Gani.
The Gani group claimed that they were no longer related to the other two companies (the Wonderful group) as the shareholding relationship between them had ceased as of March 2011.
Začetek delnega vmesnega pregleda
The Gani group therefore requested an interim review of the measures in force, as the single duty rate in force was no longer appropriate.
Komisija je po posvetovanju s svetovalnim odborom ugotovila, da bi bilo treba začeti tak pregled.
Initiation of a partial interim review
Komisija je 31. januarja 2014 v skladu s členom 11(3) osnovne uredbe začela delni vmesni pregled veljavnih ukrepov za uvoz keramičnih ploščic s poreklom iz Ljudske republike Kitajske v Unijo.
The Commission determined, after having consulted the Advisory Committee, that such a review should therefore be opened.
Obvestilo o začetku je objavila v Uradnem listu Evropske unije [3].
On 31 January 2014, the Commission initiated a partial interim review of the measures in force on imports into the Union of ceramic tiles originating in the People's Republic of China under Article 11(3) of the basic Regulation.
Pregled je bil po obsegu omejen na preiskavo lastniške strukture skupine Gani, po potrebi pa je bila po uradni dolžnosti pregledana tudi stopnja dampinga v zvezi s skupino Gani.
It published a Notice of Initiation in the Official Journal of the European Union [3].
Pregled je po uradni dolžnosti zajemal iste zadeve tudi glede skupine Wonderful.
The review was limited in scope to the examination of the ownership structure of the Gani group and, if warranted, ex officio of the dumping margin as far as the Gani group was concerned.
Obdobje preiskave v zvezi s pregledom
The review also covered ex officio the same matters as far as the Wonderful group was concerned.
Preiskava dampinga je zajela obdobje od 1. januarja 2013 do 31. decembra 2013 („obdobje preiskave v zvezi s pregledom“).
Review investigation period
Strani, ki jih preiskava zadeva
The investigation of dumping covered the period from 1 January 2013 to 31 December 2013 (‘the review investigation period’).
Komisija je pozvala skupino Gani in skupino Wonderful, naj sodelujeta v preiskavi in izpolnita vprašalnike Komisije.
Parties concerned by the investigation
Komisija je družbam tudi zagotovila možnost, da zahtevajo tržnogospodarsko obravnavo iz člena 2(7) osnovne uredbe.
The Commission invited both the Gani group and the Wonderful group to cooperate with the investigation and to reply to the Commission's questionnaires.
V obvestilu o začetku je Komisija kot tretjo državo s tržnim gospodarstvom („primerljiva država“) v smislu člena 2(7)(a) osnovne uredbe začasno izbrala Združene države Amerike, zainteresirane strani pa je pozvala, naj podajo pripombe na to izbiro.
In addition, the Commission provided an opportunity for the companies to request market economy treatment under Article 2(7) of the basic Regulation.
Zainteresirane strani so imele možnost predložiti pripombe v zvezi z začetkom preiskave in zahtevati zaslišanje pred Komisijo in/ali pooblaščencem za zaslišanje v trgovinskih postopkih.
In the Notice of Initiation the Commission had provisionally chosen the United States of America as a third market economy country (‘analogue country’) within the meaning of Article 2(7)(a) of the basic Regulation and invited parties to comment on this choice.
Izpolnjeni vprašalniki in preveritveni obiski
Interested parties had an opportunity to comment on the initiation of the investigation and to request a hearing with the Commission and/or the Hearing Officer for trade proceedings.
Komisija je prejela izpolnjene vprašalnike od obeh skupin in od dveh proizvajalcev iz primerljive države.
Questionnaire replies and verification visits
Komisija je zbrala in preverila vse informacije, ki so bile po njenem mnenju potrebne za pregled.
The Commission received questionnaire replies from both groups and also from two analogue country producers.
Preveritveni obiski v skladu s členom 16 osnovne uredbe so bili opravljeni v prostorih naslednjih družb:
The Commission sought and verified all the information deemed necessary for the review.
proizvajalci izvozniki v zadevni državi:
Exporting producers in the country concerned:
Ltd in
Foshan Gani Ceramics Co.
proizvajalci iz primerljive države, ki so zaprosili za zaupno obravnavo zaradi tveganja povračilnih ukrepov.
Ltd
ZADEVNI IZDELEK
Producers in the analogue country that requested confidential treatment on the basis of risk of retaliation.
Izdelek, ki se pregleduje, je enak izdelku, ki je opredeljen v prvotni uredbi, tj. glazirane in neglazirane keramične ploščice za tlakovanje in oblaganje, glazirane in neglazirane keramične kockice za mozaik in podobno, na podlagi ali brez podlage („zadevni izdelek“), ki se trenutno uvrščajo v oznake KN 69071000, 69079020, 69079080, 69081000, 69089011, 69089020, 69089031, 69089051, 69089091, 69089093 in 69089099.
PRODUCT CONCERNED
DAMPING
The product subject to this review is the same as defined in the original Regulation, namely glazed and unglazed ceramic flags and paving, hearth or wall tiles; glazed and unglazed ceramic mosaic cubes and the like, whether or not on a backing (‘the product concerned’), currently falling within CN codes 69071000, 69079020, 69079080, 69081000, 69089011, 69089020, 69089031, 69089051, 69089091, 69089093 and 69089099.
Tržnogospodarska obravnava
DUMPING
Nobena skupina ni zahtevala tržnogospodarske obravnave iz člena 2(7)(c) osnovne uredbe.
Market Economy Treatment
Primerljiva država
Neither group requested market economy treatment under Article 2(7)(c) of the basic Regulation.
Kot je navedeno zgoraj, je Komisija kot že v prejšnji preiskavi za primerljivo državo predlagala Združene države Amerike.
Analogue Country
Komisija je stopila v stik tudi z družbami v več drugih možnih primerljivih državah, vendar od nobene ni prejela odgovora ali pristanka na sodelovanje.
As set out above, the Commission proposed the United States of America as analogue country, as it had been in the previous investigation.
Izbira Združenih držav Amerike je bila zato potrjena kot ustrezna.
The Commission also contacted companies in a number of other possible analogue countries, but received no replies or cooperation from any other company.
Preiskava
The choice of the United States of America was therefore confirmed as appropriate.
V preiskavi, ki je privedla do uvedbe veljavnih ukrepov, je bilo ugotovljeno, da sta bili skupini Gani in Wonderful povezani, saj je imel eden od delničarjev skupine Wonderful v lasti več kot 5 % delnic ene od družb v skupini Gani.
Investigation
Stopnja dampinga je bila izračunana ločeno za vsako skupino.
The investigation leading to the imposition of the measures in force established that the Gani group and the Wonderful group were related, in so far as one of the shareholders of the Wonderful group owned more than 5 % of the shares in a company in the Gani group.
Stopnja odprave škode je bila pri obeh skupinah višja od stopnje dampinga.